首页> 外国专利> COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT, METHODS FOR IMPROVING SLEEP QUALITY IN A MAMMAL PATIENT, TO TREAT ON THE INSTITUTE PATIENT AND TRAFFICKING IN A MAMMALIAN PATIENT

COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT, METHODS FOR IMPROVING SLEEP QUALITY IN A MAMMAL PATIENT, TO TREAT ON THE INSTITUTE PATIENT AND TRAFFICKING IN A MAMMALIAN PATIENT

机译：相同或药物可接受的复合盐，药物成分，使用复合或药学可接受的盐，改善哺乳动物患者睡眠质量的方法，以治疗院内患者和贩运哺乳动物患者

页面导航

摘要
著录项
相似文献

摘要

The present invention is directed to substituted diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

机译：本发明涉及取代的泽西潘化合物，其是食欲素受体的拮抗剂，并且可用于治疗或预防涉及食欲素受体的神经和精神疾病和疾病。本发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在预防或治疗涉及食欲素受体的此类疾病中的用途。

著录项

公开/公告号BRPI0719361A2

专利类型
公开/公告日2014-02-04

原文格式PDF
申请/专利权人 MERCK & CO. INC.;
展开▼

申请/专利号BR2007PI19361
发明设计人 JEFFREY M. BERGMAN;MICHAEL J. BRESLIN;PAUL J. COLEMAN;CHRISTOPHER D. COX;SWATI P. MERCER;ANTHONY J. ROECKER;
展开▼

申请日2007-11-30
分类号C07D401/14;A61K31/551;A61P3/04;A61P25/20;C07D403/14;C07D413/14;C07D471/04;C07D487/04;C07D491/048;C07D491/052;C07D495/04;
国家 BR
入库时间 2022-08-21 15:58:37

相似文献

专利
外文文献
中文文献